-transparent.png){kind=logo}
Electrophysiological changes produced by intravenous (0.1 mg/kg) metoprolol, a new selective beta 1-blocking agent devoid of intrinsic activity, were studied in 16 subjects with estimated normal impulse formation and conduction. The most important effects were sinus bradycardia, mild increase of sinoatrial conduction time, depression of intranodal conduction, and prolongation of AV node refractory periods. Sinus node recovery time and atrial refractory periods were unmodified. Infranodal conduction and the refractory periods of the His-Purkinje system, as well as of the bundle-branches, were unchanged. These effects are compared with those observed after intravenous propranolol, pindolol, and oxprenolol.
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
September 1981,
Archives des maladies du coeur et des vaisseaux,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
May 1982,
Clinical cardiology,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
January 1991,
European journal of clinical pharmacology,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
November 1984,
European heart journal,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
September 1977,
British heart journal,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
August 1987,
Archives des maladies du coeur et des vaisseaux,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
January 1986,
European journal of clinical pharmacology,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
January 1981,
European journal of clinical pharmacology,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
November 2018,
Experimental and therapeutic medicine,
P Rizzon, and
M Di Biase, and
A Chiddo, and
D Mastrangelo, and
L Sorgente
March 1977,
British heart journal,
